Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2025
Resources
All Resources
2024 Savings Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Press Releases
Press Release
Share
Press Release
Dec 7, 2020
| Rachel Schwartz
AAM Statement on President-elect Biden Naming Xavier Becerra as Secretary of Health and Human Services
Press Release
Nov 20, 2020
| Rachel Schwartz
AAM Statement on Trump’s Drug Pricing Ruling – Rebates and Most Favored Nation Model
Press Release
Nov 11, 2020
| Rachel Schwartz
AAM Statement on 2020 Election
Press Release
Oct 7, 2020
| Rachel Schwartz
AAM Statement on the Introduction of the Protecting Access to Affordable Medicines Act of 2020
Press Release
Sep 29, 2020
| Rachel Schwartz
AAM Releases 12th Annual Access & Savings Report
Press Release
Aug 25, 2020
| Rachel Schwartz
Association for Accessible Medicines Names New President and CEO
Press Release
Aug 10, 2020
| Rachel Schwartz
Lisa Steelman Joins AAM as Vice President, State Government Affairs
Press Release
Aug 6, 2020
| Rachel Schwartz
Generic and Biosimilar Industry Statement on Essential Medicines Executive Order
Press Release
Jul 2, 2020
| Rachel Schwartz
AAM Commends Introduction of the Increasing Access to Biosimilars Act
Press Release
Jun 18, 2020
| Rachel Schwartz
AAM Statement on USTR Lighthizer’s House Testimony on USMCA
Press Release
Jun 2, 2020
| Rachel Schwartz
AAM Statement on Senate Finance Hearing on FDA’s Foreign Manufacturing Inspection Process
Press Release
May 14, 2020
| Rachel Schwartz
AAM Files Amicus Brief Supporting the BPCIA
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2025
Resources
All Resources
2024 Savings Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action